These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 30208640

  • 1. Peptides as Therapeutic Agents for Inflammatory-Related Diseases.
    La Manna S, Di Natale C, Florio D, Marasco D.
    Int J Mol Sci; 2018 Sep 11; 19(9):. PubMed ID: 30208640
    [Abstract] [Full Text] [Related]

  • 2. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.
    Motilva V, Talero E, Calvo JR, Villegas I, Alarcón-de-la-Lastra C, Sánchez-Fidalgo S.
    Curr Pharm Des; 2008 Sep 11; 14(1):71-95. PubMed ID: 18220820
    [Abstract] [Full Text] [Related]

  • 3. Peptides and peptidomimetics as immunomodulators.
    Gokhale AS, Satyanarayanajois S.
    Immunotherapy; 2014 Sep 11; 6(6):755-74. PubMed ID: 25186605
    [Abstract] [Full Text] [Related]

  • 4. Igniting Small-Molecule Drug Discovery.
    Steinhagen H.
    ChemMedChem; 2016 Jan 19; 11(2):148-9. PubMed ID: 26781775
    [Abstract] [Full Text] [Related]

  • 5. The potential of food protein-derived anti-inflammatory peptides against various chronic inflammatory diseases.
    Majumder K, Mine Y, Wu J.
    J Sci Food Agric; 2016 May 19; 96(7):2303-11. PubMed ID: 26711001
    [Abstract] [Full Text] [Related]

  • 6. Cortistatin as a potential multistep therapeutic agent for inflammatory disorders.
    Gonzalez-Rey E, Delgado M.
    Drug News Perspect; 2006 Sep 19; 19(7):393-9. PubMed ID: 17080202
    [Abstract] [Full Text] [Related]

  • 7. Annexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and Clearance.
    Sugimoto MA, Vago JP, Teixeira MM, Sousa LP.
    J Immunol Res; 2016 Sep 19; 2016():8239258. PubMed ID: 26885535
    [Abstract] [Full Text] [Related]

  • 8. Anti-inflammatory peptides and proteins in inflammatory bowel disease.
    Veljaca M.
    Curr Opin Investig Drugs; 2001 Oct 19; 2(10):1387-94. PubMed ID: 11890353
    [Abstract] [Full Text] [Related]

  • 9. Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development.
    Caliendo G, Santagada V, Perissutti E, Severino B, Fiorino F, Frecentese F, Juliano L.
    J Med Chem; 2012 Aug 09; 55(15):6669-86. PubMed ID: 22607152
    [No Abstract] [Full Text] [Related]

  • 10. From willow bark to peptides: the ever widening spectrum of NF-kappaB inhibitors.
    D'Acquisto F, Ianaro A.
    Curr Opin Pharmacol; 2006 Aug 09; 6(4):387-92. PubMed ID: 16781194
    [Abstract] [Full Text] [Related]

  • 11. Peptide nanomaterials as future antimicrobial technologies.
    Laverty G.
    Future Microbiol; 2018 Jan 09; 13():5-7. PubMed ID: 29199455
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis.
    Heinbockel L, Marwitz S, Barcena Varela S, Ferrer-Espada R, Reiling N, Goldmann T, Gutsmann T, Mier W, Schürholz T, Drömann D, Brandenburg K, Martinez de Tejada G.
    PLoS One; 2015 Jan 09; 10(7):e0133291. PubMed ID: 26197109
    [Abstract] [Full Text] [Related]

  • 13. Non-inflammatory Physiology of "Inflammatory" Mediators - Unalamation, a New Paradigm.
    Maddipati KR.
    Front Immunol; 2020 Jan 09; 11():580117. PubMed ID: 33117385
    [Abstract] [Full Text] [Related]

  • 14. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
    Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, Yao Y.
    Pharmacol Ther; 2014 Feb 09; 141(2):125-39. PubMed ID: 24076269
    [Abstract] [Full Text] [Related]

  • 15. Emerging peptide therapeutics for inflammatory diseases.
    Vally M, Seenu S, Pillarisetti S.
    Curr Pharm Biotechnol; 2006 Aug 09; 7(4):241-6. PubMed ID: 16918401
    [Abstract] [Full Text] [Related]

  • 16. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases.
    Delgado M, Abad C, Martinez C, Juarranz MG, Arranz A, Gomariz RP, Leceta J.
    J Mol Med (Berl); 2002 Jan 09; 80(1):16-24. PubMed ID: 11862320
    [Abstract] [Full Text] [Related]

  • 17. A Review of Stapled Peptides and Small Molecules to Inhibit Protein-Protein Interactions in Cancer.
    Iyer VV.
    Curr Med Chem; 2016 Jan 09; 23(27):3025-3043. PubMed ID: 27356541
    [Abstract] [Full Text] [Related]

  • 18. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A, Ottani A, Sandrini M.
    Pharmacol Res; 2001 Dec 09; 44(6):437-50. PubMed ID: 11735348
    [Abstract] [Full Text] [Related]

  • 19. Hunter-killer peptide (HKP) for targeted therapy.
    Ellerby HM, Bredesen DE, Fujimura S, John V.
    J Med Chem; 2008 Oct 09; 51(19):5887-92. PubMed ID: 18828573
    [No Abstract] [Full Text] [Related]

  • 20. Snake Venom Peptides and Low Mass Proteins: Molecular Tools and Therapeutic Agents.
    Almeida JR, Resende LM, Watanabe RK, Carregari VC, Huancahuire-Vega S, da S Caldeira CA, Coutinho-Neto A, Soares AM, Vale N, de C Gomes PA, Marangoni S, de A Calderon L, Da Silva SL.
    Curr Med Chem; 2017 Oct 09; 24(30):3254-3282. PubMed ID: 27804880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.